Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of HPV-16/18 vaccine and Twinrix Paediatric in healthy girls aged 9-15 years
2007-004347-30Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human papillomavirus type 16 L1 capsid protein antigen and hepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed) in human papillomavirus infection, hepatitis A (HAV) and hepatitis B (HBV) (3 arms), sponsored by GSK. Primary endpoint: Anti-HAV seroconversion status at Month 7. Started Oct 2007; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigenhepatitis A (inactivated) and hepatitis B (rDNA) vaccine (adsorbed)
03
Conditions
human papillomavirus infectionhepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2007-004347-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004347-30.